Genmab | Interessi Passivi Sul Debito

Created with Highcharts 10.1.0Chart context menu

There is no data for this indicator or it is unavailable at the moment



Interest Expense On Debt Cambiamento Data
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Amarin USD 0 8K 2024-06
Amgen USD 747M 29M 2024-12
argenx SE 704K 28K 2024-12
AstraZeneca 429M 28M 2024-12
Bayer 703M 61M 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Demant 462M 438.85M 2024-12
Exelixis 23.4M 3.9M 2023-09
Fresenius Medical Care EUR 101M 2M 2024-12
Galapagos EUR 50.12M 49.87M 2024-09
Genmab DKK 2.68B 1.98B 2024-12
GlaxoSmithKline 173M 17M 2024-12
GN Store Nord 295M 280.5M 2024-12
GRIFOLS EUR 202.71M 94.07M 2024-06
Hikma Pharmaceutical 22M 9M 2024-06
Insmed USD 19.8M 532K 2024-12
Lonza CHF 59M 6M 2024-06
Merck 89M 17M 2024-09
Novartis USD 275M 11M 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 62M 17M 2024-12



Genmab Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.